![]() |
MANAGEMENT OF HYPERTENSION
Non-pharmacological treatment
- Non-pharmacological treatment should be employed in all hypertensives. It may be fully effective, or may reduce the dose of drug required.
- It is the appropriate treatment for patients with diastolic pressure 90 - 94 mmHg and without target organ damage. It comprises:
- reduction of obesity
- a decrease in dietary sodium to 60 - 100 mmol/day (3.5 - 5.5 g per day as sodium chloride)
- curtailed intake of alcohol
- These measures are all of proven benefit, though individual response varies.
- The effects tend to be additive and are of useful extent.
- The goal for blood pressure reduction is:
- systolic pressure 140 mmHg or less
- diastolic pressure 85 - 90 mmHg or less; but after the age of 75 this goal should be less ambitious
Drug treatment
Drug treatment commences with monotherapy, using:
- Thiazide diuretics:
- preferably at low dosage (e.g. hydrochlorothiazide 6 - 12 mg/day) which may lessen side effects
- thiazides should be avoided in diabetics, in hyperlipidaemia and in those with low HDL cholesterol, since these conditions may be worsened
- clinical trial evidence of reduced cardiovascular disease
- Beta-blockers (especially if angina is also present):
- can adversely affect triglyceride and HDL levels
- side effects are less frequent with cardioselective and vasodilator beta-blockers and those with intrinsic sympathomimetic activity
- clinical trial evidence of reduced cardiovascular disease
- ACE inhibitors (especially if left ventricular hypertrophy or cardiac failure is present):
- relatively well tolerated
- no adverse lipid effects
- renal function must be tested before commencing treatment with an ACE inhibitor as it can worsen rapidly if renal artery stenosis is present (suspect if peripheral vascular disease is present)
- Calcium channel blockers:
- relatively well tolerated
- no adverse lipid effects
- may have antiatherogenic action
- Two or more drugs are needed in 50% of hypertensives, e.g. ACE inhibitor with low-dose thiazide or calcium antagonist; or beta-blocker with calcium antagonist or low-dose thiazide.
![]()
![]()
CARDIOnet® - registered trade mark name.
Copyright © 1996-2004 by CARDIOnet®. All rights reserved.